JMP Securities reiterated coverage on Axogen with a new price target

11/4/21 9:38:24 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

JMP Securities reiterated coverage of Axogen with a rating of Market Outperform and set a new price target of $20.00 from $25.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AXGN

Date	Price Target	Rating	Analyst
3/17/2025	$30.00	Buy	Lake Street
7/1/2024	$13.00	Outperform	Raymond James
11/11/2022	$15.00	Buy	Jefferies
5/9/2022	$10.00 → $15.00	Hold → Buy	Canaccord Genuity
3/11/2022	$21.00	Overweight	Cantor Fitzgerald
11/4/2021	$25.00 → $20.00	Market Outperform	JMP Securities